JAK Inhibitors Prior to Allogeneic Stem Cell Transplant for Patients with Myelofibrosis: A Prospective Study

被引：0
|
作者：
Salit, Rachel B. [1 ]
Stevens, Emily [2 ]
Baker, Kelsey [1 ]
Scott, Bart L. [3 ]
Gooley, Ted Alan [1 ]
Deeg, H. Joachim [4 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[3] Fred Hutchinson Canc Res Ctr, Transplantat Biol, 1124 Columbia St, Seattle, WA 98104 USA
[4] Fred Hutchinson Canc Res Ctr, Div Clin Res, Transplantat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [21] Impact of ruxolitinib in myelofibrosis post allogeneic stem cell transplant: A pilot study.
    Poulose, Joyson
    Pu, Jeffrey J.
    Malysz, Jozef
    Bayerl, Michael
    Fanburg-Smith, Julie
    Hohl, Raymond J.
    Mineishi, Shin
    Zhu, Junjia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Impact of Ruxolitinib in Myelofibrosis Allogeneic Stem Cell Transplant Outcome---a Pilot Study
    Poulose, Joyson
    Malysz, Jozef
    Claxton, David F.
    Ehmann, W. Christopher
    Mineishi, Shin
    Rybka, Witold B.
    Hohl, Raymond J.
    Pu, Jeffrey J.
    BLOOD, 2017, 130
  • [23] JAK inhibitors before, during and after stem cell transplantation for myelofibrosis
    McLornan, D.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S120 - S120
  • [24] Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
    Kroeger, Nicolaus
    Sbianchi, Giulia
    Sirait, Tiarlan
    Wolschke, Christine
    Beelen, Dietrich
    Passweg, Jakob
    Robin, Marie
    Vrhovac, Radovan
    Helbig, Grzegorz
    Sockel, Katja
    Conneally, Eibhlin
    Rubio, Marie Therese
    Beguin, Yves
    Finke, Juergen
    Bernasconi, Paolo
    Morozova, Elena
    Clausen, Johannes
    von dem Borne, Peter
    Schaap, Nicolaas
    Schroyens, Wilfried
    Patriarca, Francesca
    Di Renzo, Nicola
    Yegin, Zeynep Arzu
    Hayden, Patrick
    McLornan, Donal
    Yakoub-Agha, Ibrahim
    LEUKEMIA, 2021, 35 (12) : 3551 - 3560
  • [25] Use of the JAK2 inhibitor ruxolitinib in myelofibrosis relapsing post allogeneic stem cell transplant: case report
    Publicover, A.
    Ganczakowski, M.
    Duncombe, A.
    Hill, K.
    Hurlock, C.
    Jenner, M.
    Main, S.
    McKeag, N.
    Newman, J.
    Richardson, D. S.
    Orchard, K. H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 : 62 - 62
  • [26] Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
    Nicolaus Kröger
    Giulia Sbianchi
    Tiarlan Sirait
    Christine Wolschke
    Dietrich Beelen
    Jakob Passweg
    Marie Robin
    Radovan Vrhovac
    Grzegorz Helbig
    Katja Sockel
    Eibhlin Conneally
    Marie Thérèse Rubio
    Yves Beguin
    Jürgen Finke
    Paolo Bernasconi
    Elena Morozova
    Johannes Clausen
    Peter von dem Borne
    Nicolaas Schaap
    Wilfried Schroyens
    Francesca Patriarca
    Nicola Di Renzo
    Zeynep Arzu Yeğin
    Patrick Hayden
    Donal McLornan
    Ibrahim Yakoub-Agha
    Leukemia, 2021, 35 : 3551 - 3560
  • [27] Psychosocial factors associated with quality of life in allogeneic stem cell transplant patients prior to transplant
    Pillay, Brindha
    Lee, Stuart J.
    Katona, Lynda
    Burney, Sue
    Avery, Sharon
    PSYCHO-ONCOLOGY, 2014, 23 (06) : 642 - 649
  • [28] Psychosocial Factors Predicting Quality of Life in Allogeneic Stem Cell Transplant Patients Prior to Transplant
    Pillay, Brindha
    Lee, Stuart
    Katona, Lynda
    Burney, Sue
    Avery, Sharon
    PSYCHO-ONCOLOGY, 2014, 23 : 102 - 103
  • [29] Allogeneic Stem Cell Transplant for Myelofibrosis and Myelodysplastic Syndromes: A Contemporary Review
    Gagelmann, Nico
    Kroeger, Nicolaus
    AMERICAN JOURNAL OF HEMATOLOGY, 2025,
  • [30] Assessment of Quality of Life Following Allogeneic Stem Cell Transplant for Myelofibrosis
    Palmer, Jeanne
    Kosiorek, Heidi E.
    Wolschke, Christine
    Fauble, Veena D. S.
    Butterfield, Richard, III
    Geyer, Holly
    Scherber, Robyn M.
    Dueck, Amylou C.
    Gathany, Allison
    Mesa, Ruben A.
    Kroeger, Nicolaus
    BLOOD, 2018, 132
12345